Cargando…
Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells
Mdm2 is the major negative regulator of p53 tumor suppressor activity. This oncoprotein is overexpressed in many human tumors that retain the wild type p53 allele. As such, targeted inhibition of Mdm2 is being considered as a therapeutic anticancer strategy. The N-terminal hydrophobic pocket of Mdm2...
Autores principales: | Wade, Mark, Li, Yao-Cheng, Matani, Anand, Braun, Simon M G, Milanesi, Francesca, Rodewald, Luo Wei, Wahl, Geoffrey M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337965/ https://www.ncbi.nlm.nih.gov/pubmed/22266850 http://dx.doi.org/10.1038/onc.2011.625 |
Ejemplares similares
-
MDM2-C Functions as an E3 Ubiquitin Ligase
por: Kim, Jun Yeob, et al.
Publicado: (2020) -
The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
por: Coffill, Cynthia R., et al.
Publicado: (2016) -
MDM2 is a novel E3 ligase for HIV-1 Vif
por: Izumi, Taisuke, et al.
Publicado: (2009) -
MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity
por: He, Ying, et al.
Publicado: (2013) -
Tau protein binds to the P53 E3 ubiquitin ligase MDM2
por: Sola, Martina, et al.
Publicado: (2023)